News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
191 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (15)
2 (202)
3 (277)
4 (157)
5 (4)
6 (20)
7 (338)
8 (259)
9 (169)
10 (136)
11 (69)
12 (2)
13 (5)
14 (180)
15 (278)
16 (196)
17 (214)
18 (92)
19 (3)
20 (8)
21 (80)
22 (246)
23 (224)
24 (214)
25 (91)
26 (1)
27 (5)
28 (191)
29 (236)
30 (198)
31 (235)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
FDA
U.S. FDA Approves IMBRUVICA® (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Patients treated with IMBRUVICA plus obinutuzumab experienced a 77 percent reduction in risk of progression or death compared to chlorambucil plus obinutuzumab
January 28, 2019
·
13 min read
GeneNews Publishes Data on ColonSentry in Colorectal Cancer Risk Assessment
Study demonstrates validity of blood-based biomarker test as an adjunct method to colon cancer screening tests in non-compliant patient populations
January 28, 2019
·
5 min read
Business
Purdue Pharma L.P. and Alivio Therapeutics Enter into Partnership to Advance ALV-107, a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome Treatment
Alivio to receive up to $14.75 million in upfront and near-term license exercise payments and is eligible to receive royalties on product sales and over $260 million in research and development milestones
January 28, 2019
·
5 min read
Business
Ketologie Expands its Reach in the U.S. with Delicious and Easy Keto Shakes
Ketologie, a Dallas-based health and wellness company, is spreading the word about the health benefits of a low-carb, high-fat Keto Diet.
January 28, 2019
·
2 min read
Business
Muno-Vax Biotechnologies Revolutionizes Immune System Nutritional Supplements
Muno-Vax Biotechnologies is revolutionizing the nutritional supplement industry with its new line of products that boosts the immune system to help prevent respiratory infections, gingivitis and prostate problems.
January 28, 2019
·
2 min read
Business
Neopharm’s Ultimate Joint Elements and Supreme Probiotic Elements Now Available on Amazon
NeoPharm, the fastest-growing pharmaceutical company in Bulgaria, announced that it now has Ultimate Joint Elements and Supreme Probiotic Elements live on Amazon.
January 28, 2019
·
2 min read
Redsense Develops Prototype Based on its Innovative Smart Wound Care Technology for Optical Measuring of Blood and Exudate
Redsense Medical announces that the company has started the development of a prototype with fully functional optical measuring based on the innovative, smart wound technology that was presented in November 2018.
January 28, 2019
·
2 min read
Silken Laumann empowers Canadians to walk the talk when it comes to mental health with project UNSINKABLE
Get ready to feel inspired, Canadians. Silken Laumann reveals UNSINKABLE, a story-sharing platform to empower Canadians to walk the talk when it comes to mental health.
January 28, 2019
·
2 min read
Policy
Provention Bio Receives Notice of Allowance from United States Patent and Trademark Office for Patent on Multi-Strain Coxsackievirus B Vaccine for Preventing or Treating Type 1 Diabetes (T1D)
Provention is currently developing PRV-101 as a polyvalent vaccine for acute coxsackie virus infection and to potentially prevent the onset of T1D
January 28, 2019
·
3 min read
Business
Healthstat Selected by Johns Hopkins HealthCare to Provide Its Evidence-based Employee Health Programs to Onsite Clinics
Healthstat, Inc. today announced a 5-year agreement with Johns Hopkins HealthCare, LLC to market, license and implement employee health programs developed by Johns Hopkins Medicine.
January 28, 2019
·
2 min read
Previous
4 of 20
Next